Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Protein-protein Interfaces02:04

Protein-protein Interfaces

14.9K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
14.9K
Protein-Protein Interfaces02:04

Protein-Protein Interfaces

4.6K
4.6K
Protein Complexes with Interchangeable Parts01:57

Protein Complexes with Interchangeable Parts

3.0K
Groups of proteins may form a complex where each protein in this complex has a different role in the overall execution of the complex’s function. Often some of the proteins in the complex can be replaced by a closely related variant to give a complex that contains many of the same components yet is functionally distinct.
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
3.0K
Protein Complexes with Interchangeable Parts01:57

Protein Complexes with Interchangeable Parts

2.2K
2.2K
Assembly of Signaling Complexes01:30

Assembly of Signaling Complexes

7.0K
Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
7.0K
Structure of Cadherins01:25

Structure of Cadherins

5.1K
The cadherins were one of the first cell adhesion molecules discovered; the term “cadherins”   is based on their calcium-dependent adhering properties. The first cadherins discovered on the epithelial, neuronal, and placental cells were named E-cadherin, P-cadherin, and N-cadherin, respectively. These classical cadherins share sequence and structural similarities. Other cadherins, including those involved in cell signaling, are grouped into non-classical cadherins. This...
5.1K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Fragment-Based Development of Small Molecule Inhibitors Targeting <i>Mycobacterium tuberculosis</i> Cholesterol Metabolism.

Journal of medicinal chemistry·2025
Same author

Fragment-based development of small molecule inhibitors targeting <i>Mycobacterium tuberculosis</i> cholesterol metabolism.

bioRxiv : the preprint server for biology·2025
Same author

Selective Aurora A-TPX2 Interaction Inhibitors Have <i>In Vivo</i> Efficacy as Targeted Antimitotic Agents.

Journal of medicinal chemistry·2024
Same author

A Fragment-Based Competitive <sup>19</sup>F LB-NMR Platform For Hotspot-Directed Ligand Profiling.

Angewandte Chemie (International ed. in English)·2024
Same author

Chemical Validation of <i>Mycobacterium tuberculosis</i> Phosphopantetheine Adenylyltransferase Using Fragment Linking and CRISPR Interference.

Angewandte Chemie (Weinheim an der Bergstrasse, Germany)·2024
Same author

Mono-2-ethylhexylphthalate (MEHP) is a potent agonist of human TRPA1 channel.

Chemosphere·2023

関連する実験動画

Updated: Mar 13, 2026

A Guide to Production, Crystallization, and Structure Determination of Human IKK1/&#945;
11:27

A Guide to Production, Crystallization, and Structure Determination of Human IKK1/α

Published on: November 2, 2018

9.6K

生物物理的断片ベースのアプローチを使用して,CK2βにおける構成的,ホモジメのタンパク質-タンパク質インターフェースを破壊する.

Wei-Guang Seetoh1, Chris Abell1

  • 1Department of Chemistry, University of Cambridge , Lensfield Road, Cambridge, CB2 1EW, United Kingdom.

Journal of the American Chemical Society
|October 12, 2016
PubMed
まとめ
この要約は機械生成です。

研究者達は タンパク質のインターフェイスを 破壊する小さな分子を 特定しました この方法はCK2βホモディマーを標的とし,他のタンパク質複合体を分解してその機能を制御するのに役立ちます.

さらに関連する動画

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

11.9K
Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes
07:22

Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes

Published on: January 12, 2024

4.7K

関連する実験動画

Last Updated: Mar 13, 2026

A Guide to Production, Crystallization, and Structure Determination of Human IKK1/&#945;
11:27

A Guide to Production, Crystallization, and Structure Determination of Human IKK1/α

Published on: November 2, 2018

9.6K
Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

11.9K
Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes
07:22

Author Spotlight: Evaluating Biophysical Assays for Characterizing PROTACS Ternary Complexes

Published on: January 12, 2024

4.7K

科学分野:

  • 生物化学
  • 分子生物学
  • 薬物の発見

背景:

  • 構成タンパク質とタンパク質の相互作用を小分子で破壊することは,薬剤発見における重要な課題です.
  • カゼインキナーゼ2βサブユニット (CK2β) は,その機能に不可欠なホモディメール構造を形成する.

研究 の 目的:

  • CK2βの構成ホモディメア界面を乱すことができる小分子を特定する.
  • 生物学的スクリーニングカスケードを確立して 破壊的な分子を特定する.

主な方法:

  • 標的の生物学的スクリーニングのカスケードを利用した.
  • CK2βのホモディメアタンパク質-タンパク質インターフェースを破壊することに焦点を当てています.

主要な成果:

  • CK2βホモディメア界面を乱す小分子を成功裏に特定した.
  • この目的のために生物学的スクリーニングカスケードを使用する可能性を実証しました.

結論:

  • 開発されたスクリーニングアプローチは,構成タンパク質のインターフェースを破壊する小分子を特定することができます.
  • この戦略は,他のホモオリゴメアタンパク質のサブユニット解体により,その機能を調節する可能性を秘めている.